Catalyst Pharmaceuticals, Inc. CPRX
CPRX
Catalyst Pharmaceuticals, Inc. MLYS
Mineralys Therapeutics, Inc. CDTX
Cidara Therapeutics, Inc. APLS
Apellis Pharmaceuticals, Inc. BEAM
Beam Therapeutics Inc. ADPT
Adaptive Biotechnologies Corporation SRRK
Scholar Rock Holding Corporation IDYA
IDEAYA Biosciences, Inc. RXRX
Recursion Pharmaceuticals, Inc. KNSA
Kiniksa Pharmaceuticals, Ltd.
Catalyst Pharmaceuticals, Inc. MLYS
Mineralys Therapeutics, Inc. CDTX
Cidara Therapeutics, Inc. APLS
Apellis Pharmaceuticals, Inc. BEAM
Beam Therapeutics Inc. ADPT
Adaptive Biotechnologies Corporation SRRK
Scholar Rock Holding Corporation IDYA
IDEAYA Biosciences, Inc. RXRX
Recursion Pharmaceuticals, Inc. KNSA
Kiniksa Pharmaceuticals, Ltd.
Performance
| Periode | CPRX | MLYS | CDTX | APLS | BEAM | ADPT | SRRK | IDYA | RXRX | KNSA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -9.72 % | 131.90 % | 748.82 % | 29.55 % | 53.63 % | 45.15 % | 41.93 % | 53.19 % | -15.37 % | 35.57 % |
| YTD | 6.60 % | 194.37 % | 706.23 % | -24.71 % | 11.27 % | 149.26 % | 6.09 % | 33.47 % | -36.62 % | 105.47 % |
| 1Y | 4.41 % | 178.46 % | 908.71 % | -26.57 % | -4.90 % | 141.83 % | 11.07 % | 23.50 % | -39.63 % | 92.80 % |
| 3Y | 31.76 % | 95.55 % | 1 988.24 % | -51.72 % | -37.96 % | 78.99 % | 478.40 % | 97.18 % | -48.48 % | 161.62 % |
| 5Y | 531.95 % | 95.55 % | 444.80 % | -47.84 % | -64.92 % | -72.47 % | -2.56 % | 135.81 % | -74.61 % | 125.98 % |
| 10Y | 825.00 % | 95.55 % | -31.09 % | 77.94 % | 46.58 % | -61.71 % | 202.26 % | 200.09 % | -74.61 % | 110.43 % |
| Depuis le début | 276.06 % | 95.55 % | -31.22 % | 77.94 % | 46.58 % | -61.71 % | 202.26 % | 200.09 % | -74.61 % | 110.43 % |